
PMC - PMC8551477
PMID- 34274528
IS  - 2212-8778 (Electronic)
VI  - 52
DP  - 2021 Oct
TI  - Insulin action at a molecular level – 100 years of progress.
LID - 101304
AB  - The discovery of insulin 100 years ago and its application to the treatment of
      human disease in the years since have marked a major turning point in the history
      of medicine. The availability of purified insulin allowed for the establishment
      of its physiological role in the regulation of blood glucose and ketones, the
      determination of its amino acid sequence, and the solving of its structure. Over 
      the last 50 years, the function of insulin has been applied into the discovery of
      the insulin receptor and its signaling cascade to reveal the role of impaired
      insulin signaling—or resistance—in the progression of type 2 diabetes. It has
      also become clear that insulin signaling can impact not only classical
      insulin-sensitive tissues, but all tissues of the body, and that in many of these
      tissues the insulin signaling cascade regulates unexpected physiological
      functions. Despite these remarkable advances, much remains to be learned about
      both insulin signaling and how to use this molecular knowledge to advance the
      treatment of type 2 diabetes and other insulin-resistant states.
OAB - Publisher: Abstract available from the publisher.
FAU - White, Morris F.
AU  - White MF
AD  - Boston Children's Hospital and Harvard Medical School, Boston, MA, 02215, USA
FAU - Kahn, C. Ronald
AU  - Kahn CR
AD  - Joslin Diabetes Center, Harvard Medical School, Boston, MA, 02215, USA
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20210715
PHST- 2021/03/31 [received]
PHST- 2021/07/07 [revised]
PHST- 2021/07/13 [accepted]
TA  - Mol Metab
JT  - Molecular Metabolism
AID - S2212-8778(21)00151-4 [pii]
AID - 10.1016/j.molmet.2021.101304 [doi]
SO  - Mol Metab. 2021 Jul 15;52:. doi:10.1016/j.molmet.2021.101304.

PMC - PMC9727033
PMID- 36473871
IS  - 2041-1723 (Electronic)
VI  - 13
DP  - 2022
TI  - The dynamic clustering of insulin receptor underlies its signaling and is
      disrupted in insulin resistance.
LID - 7522
AB  - Insulin receptor (IR) signaling is central to normal metabolic control and is
      dysregulated in metabolic diseases such as type 2 diabetes. We report here that
      IR is incorporated into dynamic clusters at the plasma membrane, in the cytoplasm
      and in the nucleus of human hepatocytes and adipocytes. Insulin stimulation
      promotes further incorporation of IR into these dynamic clusters in
      insulin-sensitive cells but not in insulin-resistant cells, where both IR
      accumulation and dynamic behavior are reduced. Treatment of insulin-resistant
      cells with metformin, a first-line drug used to treat type 2 diabetes, can rescue
      IR accumulation and the dynamic behavior of these clusters. This rescue is
      associated with metformin’s role in reducing reactive oxygen species that
      interfere with normal dynamics. These results indicate that changes in the
      physico-mechanical features of IR clusters contribute to insulin resistance and
      have implications for improved therapeutic approaches.
OAB - Publisher: Abstract available from the publisher.
FAU - Dall’Agnese, Alessandra
AU  - Dall’Agnese A
AD  - grid.270301.70000 0001 2292 6283Whitehead Institute for Biomedical Research,
      Cambridge, MA 02142 USA
FAU - Platt, Jesse M.
AU  - Platt JM
AD  - grid.270301.70000 0001 2292 6283Whitehead Institute for Biomedical Research,
      Cambridge, MA 02142 USA
FAU - Zheng, Ming M.
AU  - Zheng MM
AD  - grid.270301.70000 0001 2292 6283Whitehead Institute for Biomedical Research,
      Cambridge, MA 02142 USA
FAU - Friesen, Max
AU  - Friesen M
AUID- ORCID: 0000-0002-6699-6619
AD  - grid.270301.70000 0001 2292 6283Whitehead Institute for Biomedical Research,
      Cambridge, MA 02142 USA
FAU - Dall’Agnese, Giuseppe
AU  - Dall’Agnese G
AD  - grid.270301.70000 0001 2292 6283Whitehead Institute for Biomedical Research,
      Cambridge, MA 02142 USA
FAU - Blaise, Alyssa M.
AU  - Blaise AM
AUID- ORCID: 0000-0001-9958-4488
AD  - grid.270301.70000 0001 2292 6283Whitehead Institute for Biomedical Research,
      Cambridge, MA 02142 USA
FAU - Spinelli, Jessica B.
AU  - Spinelli JB
AUID- ORCID: 0000-0003-3657-4578
AD  - grid.270301.70000 0001 2292 6283Whitehead Institute for Biomedical Research,
      Cambridge, MA 02142 USA
FAU - Henninger, Jonathan E.
AU  - Henninger JE
AUID- ORCID: 0000-0002-9604-2007
AD  - grid.270301.70000 0001 2292 6283Whitehead Institute for Biomedical Research,
      Cambridge, MA 02142 USA
FAU - Tevonian, Erin N.
AU  - Tevonian EN
AD  - grid.116068.80000 0001 2341 2786Department of Biological Engineering,
      Massachusetts Institute of Technology, Cambridge, MA 02139 USA
FAU - Hannett, Nancy M.
AU  - Hannett NM
AD  - grid.270301.70000 0001 2292 6283Whitehead Institute for Biomedical Research,
      Cambridge, MA 02142 USA
FAU - Lazaris, Charalampos
AU  - Lazaris C
AUID- ORCID: 0000-0002-7345-8288
AD  - grid.270301.70000 0001 2292 6283Whitehead Institute for Biomedical Research,
      Cambridge, MA 02142 USA
FAU - Drescher, Hannah K.
AU  - Drescher HK
AD  - grid.32224.350000 0004 0386 9924Division of Gastroenterology, Department of
      Medicine, Massachusetts General Hospital, Boston, MA 02114 USA
FAU - Bartsch, Lea M.
AU  - Bartsch LM
AD  - grid.32224.350000 0004 0386 9924Division of Gastroenterology, Department of
      Medicine, Massachusetts General Hospital, Boston, MA 02114 USA
FAU - Kilgore, Henry R.
AU  - Kilgore HR
AUID- ORCID: 0000-0003-4851-9656
AD  - grid.270301.70000 0001 2292 6283Whitehead Institute for Biomedical Research,
      Cambridge, MA 02142 USA
FAU - Jaenisch, Rudolf
AU  - Jaenisch R
AUID- ORCID: 0000-0002-2540-7099
AD  - grid.270301.70000 0001 2292 6283Whitehead Institute for Biomedical Research,
      Cambridge, MA 02142 USA
FAU - Griffith, Linda G.
AU  - Griffith LG
AUID- ORCID: 0000-0002-1801-5548
AD  - grid.116068.80000 0001 2341 2786Department of Biological Engineering,
      Massachusetts Institute of Technology, Cambridge, MA 02139 USA
FAU - Cisse, Ibrahim I.
AU  - Cisse II
AUID- ORCID: 0000-0002-8764-1809
AD  - grid.116068.80000 0001 2341 2786Department of Physics, Massachusetts Institute of
      Technology, Cambridge, MA 02139 USA
FAU - Jeppesen, Jacob F.
AU  - Jeppesen JF
AD  - grid.270301.70000 0001 2292 6283Whitehead Institute for Biomedical Research,
      Cambridge, MA 02142 USA
FAU - Lee, Tong I.
AU  - Lee TI
AUID- ORCID: 0000-0003-1847-0898
AD  - grid.270301.70000 0001 2292 6283Whitehead Institute for Biomedical Research,
      Cambridge, MA 02142 USA
FAU - Young, Richard A.
AU  - Young RA
AUID- ORCID: 0000-0001-8855-8647
AD  - grid.270301.70000 0001 2292 6283Whitehead Institute for Biomedical Research,
      Cambridge, MA 02142 USA
LA  - eng
PT  - Journal Article
DEP - 20221206
PHST- 2022/10/31 [received]
PHST- 2022/11/17 [accepted]
TA  - Nat Commun
JT  - Nature Communications
AID - 35176 [pii]
AID - 10.1038/s41467-022-35176-7 [doi]
SO  - Nat Commun. 2022 Dec 6;13:. doi:10.1038/s41467-022-35176-7.
